Appointed Clinical Professor of Oral Medicine and Chief of Pharmacotherapeutic
Dr. Frederick A. Curro,
an academician, clinical researcher, and pharmacologist, has been
appointed a Clinical Professor of Oral Medicine and Chief of Pharmacotherapeutic
Research at the Bluestone Center for Clinical Research. Dr. Curro
holds both a DMD degree and a PhD in pharmacology and chaired the
Department of Pharmacology at Fairleigh Dickinson University College
of Dental Medicine. He has also been appointed coordinator of NYUCD’s
pharmacology program and a Clinical Professor of Oral Medicine.
Dr. Curro served most recently as Vice President/Director of Corporate
Clinical and Medical Affairs at GlaxoSmithKline and at Block Drug
Company, Inc., and as Executive Director of Clinical Research and
Operations for biotechnology developer Transkaryotic Therapies,
Inc., a Cambridge, Massachusetts-based proteomic/genetic biotechnology
In addition to his appointments at NYUCD, Dr. Curro will continue
to serve as a consultant on clinical pharmacology and regulatory
affairs to The Forsyth Institute and the Coast Guard Academy’s
dental clinic in New London, Connecticut, and as a visiting professor
at Tufts University School of Dental Medicine.
Appointed Associate Professor of Biomaterials and Biomimetics
expert Dr. John L. Ricci has joined the NYUCD faculty as an Associate
Professor of Biomaterials and Biomimetics. Dr. Ricci comes to NYUCD
from the University of Medicine and Dentistry of New Jersey, where
he served as an Associate Professor of Orthopedics at UMDNJ’s
medical school and as an Associate Professor of Prosthodontics and
of Biomaterials/Restorative Dentistry at UMDNJ’s dental school.
He was also an Associate Professor of Biomedical Engineering at
Rutgers University and at City College of New York.
Dr. Ricci received his PhD in anatomy from UMDNJ, where he also
completed a postdoctoral fellowship in orthopedic surgery. He has
published and lectured widely on modifying and texturing implant
surfaces to increase their adhesion to bone tissue.
Appointed Clinical Associate Professor of Oral Medicine
Ronald Katz, a member of the NYUCD faculty from 1996 to 1999, has
rejoined NYUCD as a Clinical Associate Professor of Oral Medicine.
Prior to returning to NYUCD, Dr. Katz was the John Richter Assistant
Professor of Oral Pathology at the Columbia University School of
Dental and Oral Surgery.
Dr. Katz received his dental degree from Fairleigh Dickinson University
School of Dental Medicine and a PhD in cellular and molecular biology
from the University of Michigan, and was awarded an endocrinology
fellowship from Emery University. He has been a principal investigator
and a coinvestigator on a number of NIH grants and is the author
or coauthor of over 20 papers in peer-reviewed publications. Dr.
Katz’s research interests focus on mucosal diseases affecting
the oral cavity, especially “burning tongue syndrome,”
and on translational research in the use of pharmacotherapeutics
for jawbone disease and the design of advanced bioactive coating
for dental implants.